ARTICLES BY THIS AUTHOR
- 3/27/2020
Cipla gets FDA green light for generic Nexium
Nexium and its generic versions had a market of approximately $70 million for the 12 months ended November 2019, according to IQVIA. - 3/27/2020
NACDS praises new Indiana law as vital for patient access and pharmacy viability
Senate Bill 241 will help ensure that pharmacies are more fairly and properly reimbursed. - 3/27/2020
Schnucks donates $605,000 to support people impacted by COVID-19
Schnuck is offering support to people experiencing COVID-19 related hardships in Greater St Louis, Missouri, Illinois, Indiana, Wisconsin, and Iowa. - 3/26/2020
Mylan voluntarily waives marketing exclusivity for generic Kaletra
Mylan will enable generic applicants to be eligible for FDA approval if Kaletra is found effective in treating COVID-19. - 3/26/2020
NACDS praises Administration's recommendations to governors to empower pharmacists during COVID-19
NACDS praised Secretary of HHS Alex Azar's letter to the nation’s governors asking for assistance to extend the capacity of the healthcare workforce to address the pandemic. - 3/26/2020
CPESN USA taps Bruce Kneeland to support local networks
Bruce Kneeland will help support CPESN USA's networks in several states out West. - 3/25/2020
Hy-Vee, Kroger install temporary protective windows at checkout
Hy-Vee and Kroger have installed temporary window panels at checkouts in response to the COVID-19 outbreak. - 3/25/2020
111 industry orgs urge government to maintain product supply, workforce
NACDS is among 111 organizations urging government leaders at all levels to address barriers to the COVID-19 response. - 3/25/2020
Cumberland to support treating patients with hospital-acquired and ventilator-associated pneumonia
Cumberland Pharmaceuticals is taking actions to support hospitals and clinics treating patients with hospital acquired and ventilator associated pneumonia associated with COVID-19. - 3/25/2020
CVS Caremark takes steps to protect supply of medicines potentially useful for COVID-19 treatment
CVS Health is taking additional steps to limit stockpiling of drugs that are used to treat chronic conditions as interest in off-label use of these medicines to treat COVID-19 grow.